ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Adimab broadens R&D partnerships with a trio of pharmas
May 10, 2019Adimab closed out 2018 with 10 new partnerships and six expanded deals. The drug discovery player is continuing that streak with three more deal expansions, with Novartis, Regeneron and Takeda. -
Arsanis and Adimab Enter Into License Agreement to Target Respiratory Syncytial Virus (RSV) With Mon
February 28, 2017Arsanis, Inc., a clinical-stage biopharmaceutical company developing targeted monoclonal antibodies for pre-emptive and post-infection treatment of serious infectious diseases,
Pharma Sources Insight January 2025
